Covered recipient · General Payments record
STELLA ADETOKUNBO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$328.08
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $249.59 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $43.69 | 2 |
| Amneal Pharmaceuticals LLC | $43.03 | 1 |
| LivaNova USA, Inc. | $38.43 | 1 |
| Genentech USA, Inc. | $34.07 | 1 |
| UCB, Inc. | $26.31 | 1 |
| ARGENX US, INC. | $25.45 | 1 |
| Biogen, Inc. | $19.54 | 1 |
| TG THERAPEUTICS, INC. | $19.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $22.61 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093888439 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.08 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093975148 | CMS |
| Amneal Pharmaceuticals LLC | $43.03 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139178013 | CMS |
| ARGENX US, INC. | $25.45 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142120265 | CMS |
| Biogen, Inc. | $19.54 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104862796 | CMS |
| Genentech USA, Inc. | $34.07 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133115587 | CMS |
| LivaNova USA, Inc. | $38.43 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798141 | CMS |
| TG Therapeutics, Inc. | $19.07 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136881825 | CMS |
| UCB, Inc. | $26.31 | 09/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143388297 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.